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Reduced caveolae density in 
arteries of sHR contributes to 
endothelial dysfunction and Ros 
production
simone R. potje  1, Marcella D. Grando1, Andreia Z. Chignalia2, Cristina Antoniali3 & 
Lusiane M. Bendhack1
Caveolae are plasma membrane invaginations enriched with high cholesterol and sphingolipid 
content; they also contain caveolin proteins in their structure. endothelial nitric oxide synthase 
(eNos), an enzyme that synthesizes nitric oxide (No) by converting L-arginine to L-citrulline, is highly 
concentrated in plasma membrane caveolae. Hypertension is associated with decreased No production 
and impaired endothelium-dependent relaxation. Understanding the molecular mechanisms that 
follow hypertension is important. For this study, we hypothesized that spontaneously hypertensive 
rat (sHR) vessels should have a smaller number of caveolae, and that the caveolae structure should 
be disrupted in these vessels. this should impair the eNos function and diminish No bioavailability. 
therefore, we aimed to investigate caveolae integrity and density in sHR aortas and mesenteric arteries 
and the role played by caveolae in endothelium-dependent relaxation. We have been able to show the 
presence of caveolae-like structures in sHR aortas and mesenteric arteries. Increased phenylephrine-
induced contractile response after treatment with dextrin was related to lower No release. In addition, 
impaired acetylcholine-induced endothelium-dependent relaxation could be related to decreased 
caveolae density in SHR vessels. The most important finding of this study was that cholesterol depletion 
with dextrin induced eNos phosphorylation at serine1177 (ser1177) and boosted reactive oxygen species 
(Ros) production in normotensive rat and sHR vessels, which suggested eNos uncoupling. Dextrin 
plus L-NAMe or BH4 decreased Ros production in aorta and mesenteric arteries supernatant’s of both 
sHR and normotensive groups. Human umbilical vein endothelial cells (HUVeCs) treated with dextrin 
confirmed eNOS uncoupling, as verified by the reduced eNOS dimer/monomer ratio. BH4, L-arginine, or 
BH4 plus L-arginine inhibited eNos monomerization. All these results showed that caveolae structure 
and integrity are essential for endothelium-dependent relaxation. Additionally, a smaller number of 
caveolae is associated with hypertension. Finally, caveolae disruption promotes eNos uncoupling in 
normotensive and hypertensive rat vessels and in HUVeCs.
Caveolae are flask-shaped plasma membrane invaginations enriched with cholesterol and fatty acids bearing 
straight, saturated chains, which make the structure rigid and highly organized1. Caveolae exist in many types of 
cells such as smooth muscle cells and adipocytes, but they are extremely abundant in endothelial cells2,3.
Caveolin-1 (Cav-1), a protein of 21 to 22 kD, is essential to keep caveolae organized. In agreement with this 
observation, lymphocytes and epithelial cells lacking caveolae and transfected with VIP21-Cav-1 cDNA induce 
caveolae formation4,5. In addition, Cav-1 knockout mice do not present caveolae in Cav-1-expressing tissues6,7, 
and Cav-1/Cav-3 double knockout mice do not contain caveolae in endothelial cells, smooth muscle cells, adi-
pocytes, skeletal muscle fibers, or cardiac myocytes8. Therefore, Cav-1 is an excellent biochemical marker for 
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caveolae formation and stabilization. Moreover, Cav-1 acts as chaperone and scaffold domain and may interact 
with various proteins to regulate signal transduction in caveolae9.
Endothelial nitric oxide synthase (eNOS) is a particularly interesting protein that remains associated with 
Cav-110. The enzyme eNOS generates nitric oxide (NO) by converting L-arginine to L-citrulline, a process that 
is regulated by intracellular calcium concentration and phosphorylation mediated by upstream kinases11. The 
absence of caveolae impairs eNOS activity12, NO production, calcium signaling in the cardiovascular system, 
and endothelium-dependent relaxation13–17. Thus, caveolae disruption may be a factor underlying cardiovascular 
diseases, including essential hypertension.
Spontaneously hypertensive rat (SHR) is an animal model that is used to study the established human essen-
tial hypertension18. Just as in humans, hypertension develops progressively in SHRs. Furthermore, hypertension 
progresses through different stages, namely the pre-hypertensive, gradual, and sustained hypertensive phases19, 
worsens with aging, and becomes more severe in males than in females20. SHR and normotensive Wistar-Kyoto 
rats (WKY) show similar aortic NOS activity21, but eNOS expression is higher in SHR aortas as compared to 
WKY aortas21–23. In contrast, NOS activity is lower in SHR mesenteric arteries as compared to WKY mesenteric 
arteries. However, SHR and WKY mesenteric arteries have similar eNOS expression21. Additionally, compared 
to WKY aortas, SHR aortas have down-regulated Cav-1 expression22,23 and exhibit decreased NO production 
and impaired endothelium-dependent relaxation24,25. Another model of hypertension, renal hypertensive rats (2 
Kidney-1 Clip, 2K-1C), has a smaller number of caveolae in aorta endothelial cells, which is related to impaired 
acetylcholine-induced relaxation effect26. Nevertheless, there are no data regarding the caveolae role and density 
in SHR aortas and mesenteric arteries.
Understanding the molecular mechanisms following hypertension is important. For this study, we hypoth-
esized that SHR vessels should have a smaller number of caveolae, and that the caveolae structure should be 
disrupted in these vessels. This should impair the eNOS function and diminish NO bioavailability. Therefore, we 
aimed to investigate caveolae integrity and density in SHR aortas and mesenteric arteries, the role caveolae play 
in endothelium-dependent relaxation, and the mechanisms ensuing after caveolae disruption. We compared data 
obtained with SHR and Wistar rat vessels.
Results
Caveolae disruption reduced acetylcholine (ACh)-induced endothelium-dependent relaxa-
tion. ACh-induced endothelium-dependent relaxation decreased in the SHR aortas (Fig. 1A) and mesenteric 
arteries (Fig. 1B). In the aortas, stimulation with ACh elicited similar maximum relaxant effects in normoten-
sive rats (98.4 ± 0.3%, n = 5) and SHRs (89.6 ± 0.6%, n = 7), but the ACh potency was lower in the SHR aortic 
rings (pD2: 5.75 ± 0.4, n = 7) than in the normotensive rat aortic rings (pD2: 6.51 ± 0.1, n = 5). On the other 
hand, the ACh potency values were similar in the normotensive rat (pD2: 6.94 ± 0.1, n = 7) and the SHR (pD2: 
6.92 ± 0.05, n = 6) mesenteric arteries, whereas the ACh-stimulated maximum relaxant effect was impaired in 
SHRs (60.0 ± 3.9%, n = 6) as compared to normotensive rats (94.5 ± 1.7%, n = 7).
To analyze the caveolae contribution to the ACh-induced endothelium-dependent relaxation, we used dex-
trin, an agent that depletes membrane cholesterol that is essential for caveolae stability27. In the normotensive rat 
aortas, dextrin not changed the ACh-stimulated maximum relaxant effect (91.4 ± 2.0%, n = 7), but it reduced the 
ACh potency (pD2: 5.72 ± 0.1, n = 7) (Fig. 1C). In the SHR aortas, dextrin impaired the ACh-induced maximum 
relaxant effect (45.2 ± 4.4%, n = 7) (Fig. 1E). Moreover, dextrin impaired the ACh-induced maximum relaxant 
effect in the normotensive rat (38.0 ± 7.5%, n = 6) (Fig. 1D) and SHR (19.1 ± 7.0%, n = 6) (Fig. 1F) mesenteric 
arteries.
Caveolae disassembly increased phenylephrine (pe)-induced contraction. PE induced simi-
lar contractile responses in the normotensive rat and SHR aortas and mesenteric arteries (Fig. 2A,B). Dextrin 
increased the PE-induced maximum contractile effect in the normotensive rat and SHR aortas (Fig. 2C,E). On 
the other hand, dextrin did not alter the PE-induced maximum contractile effect in the normotensive rat or SHR 
mesenteric arteries, but it increased the PE potency (Fig. 2D,F). Table 1 lists the maximum contractile effect and 
the pD2 values of the concentration-response curves constructed for the normotensive rat and SHR aortic and 
mesenteric artery rings in the presence of PE.
the number of caveolae decreased during hypertension. To analyze whether the number of caveolae 
was lower in the SHR aortas and mesenteric arteries as compared to normotensive rats and to investigate whether 
caveolae disruption with dextrin reduced caveolae integrity, we carried out electron transmission microscopy 
experiments. Figures 3B and 4B show that the normotensive rat vessels contained a larger number of caveolae 
(aortas: 136 ± 7 caveolae/μm2, n = 5; mesenteric arteries: 28 ± 1 caveolae/μm2, n = 5) as compared to the SHR 
vessels (aortas: 63 ± 7 caveolae/μm2, n = 5; mesenteric arteries: 13 ± 1 caveolae/μm2, n = 5). In both normotensive 
rats and SHRs, dextrin reduced the number of caveolae in the aortas (normotensive rats: 78 ± 11 caveolae/μm2, 
n = 5; SHRs: 38 ± 4 caveolae/μm2, n = 5) and mesenteric arteries (normotensive rats: 16 ± 1 caveolae/μm2, n = 5; 
SHRs: 8 ± 1 caveolae/μm2, n = 5). Figures 3A and 4A respectively depict the representative electron micrographs 
of caveolae-like structures in the normotensive rat and SHR aortas and mesenteric arteries treated with dextrin 
(10 mM) for 60 min or not (control).
Caveolae structural disruption promoted eNos phosphorylation. The aortas (normotensive rats: 
0.54 ± 0.07, n = 6; SHRs: 0.51 ± 0.03, n = 6) and mesenteric arteries (normotensive rats: 0.65 ± 0.03, n = 6; SHRs: 
0.80 ± 0.04, n = 6) of normotensive rats and SHRs had similar eNOS expression (Fig. 5A,B). Treatment with dex-
trin did not modify the eNOS expression in the normotensive rat vessels (Aortas: 0.65 ± 0.13, n = 6; Mesenteric 
arteries: 0.50 ± 0.06, n = 6), but it decreased the eNOS expression in the SHR vessels (Aortas: 0.23 ± 0.04, 
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n = 6; Mesenteric arteries: 0.31 ± 0.05, n = 6) (Fig. 5A,B). eNOS phosphorylation at Serine1177 (Ser1177) was 
similar in the SHR aortas (0.31 ± 0.05, n = 6) and the normotensive rat aortas (0.37 ± 0.13, n = 6) (Fig. 5C). 
However, eNOS-Ser1177 phosphorylation was more pronounced in the SHR mesenteric arteries (0.45 ± 0.04, 
n = 6) as compared to the normotensive rat mesenteric arteries (0.16 ± 0.03, n = 6) (Fig. 5D). Dextrin increased 
eNOS-Ser1177 phosphorylation in the normotensive rat and SHR aortas (normotensive rats: 0.82 ± 0.30, n = 6; 
SHRs: 2.02 ± 0.75, n = 6) and mesenteric arteries (normotensive rats: 0.72 ± 0.17, n = 6; SHRs: 0.88 ± 0.06, n = 6) 
(Fig. 5C,D). Cav-1 expression was lower in the SHR aortas (0.30 ± 0.0, n = 6) as compared to the normotensive rat 
aortas (0.75 ± 0.06, n = 6). Dextrin did not alter Cav-1 expression in any of the groups (normotensive rat aortas: 
0.69 ± 0.08, n = 6; SHR aortas: 0.23 ± 0.03, n = 6) (Fig. 5E). On the other hand, normotensive rats (0.89 ± 0.08, 
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Figure 1. Concentration-response curves constructed for the effect of acetylcholine (ACh, 0.1 nM to 0.1 mM) 
on normotensive rat and SHR (n = 5–7) endothelium-intact aortas (A,C,E) and mesenteric arteries (B,D,F) in 
the absence (Control) or in the presence of methyl-β-cyclodextrin (10 mM dextrin, for 60 min). Data represent 
the mean ± SEM of the experiments, and n represents the number of aortic or mesenteric rings used in the 
experiments. *p < 0.05 statistical difference in pD2 values between SHRs versus normotensive rats and Dextrin 
versus Control groups. ***p < 0.001 statistical difference in maximum relaxant effect values between SHRs 
versus normotensive rats and Dextrin versus Control groups.
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n = 6) and SHRs (0.89 ± 0.04, n = 6) displayed similar Cav-1 expression in the mesenteric arteries. After treat-
ment with dextrin, though, Cav-1 expression diminished in the SHR mesenteric arteries (0.35 ± 0.07, n = 6), but 
not in the normotensive rat mesenteric arteries (1.09 ± 0.12, n = 6) (Fig. 5F).
Caveolae structural disassembly reduced Nox levels and increased Ros levels. We detected 
lower NOx levels, as measured with the Griess reagent in the bath solutions of the ACh-stimulated SHR aortic 
rings (0.0921, n = 10) as compared to the NOx levels detected in the bath solutions of the normotensive rat aortic 
rings (0.1847, n = 10). Pre-treatment of the aortic rings with dextrin reduced the NOx levels in the bath solutions 
of the ACh-stimulated normotensive rat (0.0952, n = 10) and SHR (0.0641, n = 10) aortic rings (Fig. 6A).
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Figure 2. Concentration-response curves constructed for the effect of phenylephrine (PE, 0.1 nM to 0.1 mM) 
on normotensive rat and SHR (n = 5–8) endothelium-intact aortas (A,C,E) and mesenteric arteries (B,D,F) in 
the absence (Control) or in the presence of methyl-β-cyclodextrin (10 mM dextrin, for 60 min). Data represent 
the mean ± SEM of the experiments, and n represents the number of aortic or mesenteric artery rings used 
in the experiments. *p < 0.05 statistical difference in pD2 values between Dextrin versus Control groups. 
**p < 0.01 statistical difference in maximum contractile effect values between Dextrin versus Control groups.
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We achieved similar results for the bath solutions of the ACh-stimulated normotensive rat and SHR mes-
enteric artery rings. The NOx levels detected in the bath solutions of the SHR mesenteric artery rings (0.0477, 
n = 10) were almost 50% lower than the NOx levels verified in the bath solutions of the normotensive rat mesen-
teric artery rings (0.0842, n = 10). Pre-treatment with dextrin diminished the NOx levels in the bath solutions of 
both the normotensive rat (0.0438, n = 10) and SHR (0.0261, n = 10) mesenteric artery rings (Fig. 6B).
In another set of experiments, the aortic rings treated with dextrin (Normotensives: 0.196, n = 4; SHRs: 0.151, 
n = 4) or dextrin plus L-NAME (Normotensives: 0.178, n = 4; SHRs: 0143, n = 4) decreased the NOx levels compared 
to control group (Normotensives: 0.292, n = 4; SHRs: 0.188, n = 4). However, incubation with BH4 (Normotensives: 
0.236, n = 4; SHRs: 0.173, n = 4) increased the NOx levels in aortic rings treated with dextrin (Fig. 6C).
Similar results were observed in mesenteric arteries rings. Treatment with dextrin (Normotensives: 0.143, 
n = 4; SHRs: 0.124, n = 4) or dextrin plus L-NAME (Normotensives: 0.144 ± , n = 4; SHRs: 0.125, n = 4) reduced 
NOx levels compared to control group values (Normotensives: 0.199, n = 4; SHRs: 0.150, n = 4). Nevertheless, the 
NOx levels were raised in presence of BH4 (Normotensives: 0.176, n = 4; SHRs: 0.150, n = 4) almost at the same 
values of control group (Fig. 6D).
On the other hand, the ROS levels measured with the 7-CBA fluorescence probe were higher in the bath solu-
tions of the ACh-stimulated SHR vessels (Aortas: 26320.0, n = 5; Mesenteric arteries: 14130.0, n = 5) than in the 
bath solutions of the ACh-stimulated normotensive rat vessels (Aortas: 5993.0, n = 5; Mesenteric arteries: 7672.0, 
n = 5) (Fig. 7A,B). After treatment with dextrin followed by stimulation of ACh, the ROS levels increased in the 
bath solutions of the aortas (normotensive rats: 14810.0, n = 5; SHRs: 41030.0, n = 5) and mesenteric artery rings 
(normotensive rats: 15460.0, n = 5; SHRs: 36249.0, n = 5) of both groups (Fig. 7A,B).
In another set of experiments, it was observed that L-NAME or BH4 decreased ROS production promoted 
by dextrin treatment compared to control groups, both in aortic rings (Fig. 7C), as well as in rings of mesenteric 
arteries (Fig. 7D) of normotensive and SHR (Table 2).
Caveolae disruption promoted eNos uncoupling. The human umbilical vein endothelial cells 
(HUVECs) had lower eNOS dimer/monomer ratio after treatment with dextrin (0.39 ± 0.01 arbitrary units, 
n = 6) as compared to the HUVEC control (0.67 ± 0.01 arbitrary units, n = 6), which indicated eNOS uncoupling 
(Fig. 8A,B). To investigate whether supplementation with an eNOS co-factor or substrate would avoid the eNOS 
uncoupling promoted by dextrin, we used BH4 and L-arginine. On the basis of Fig. 8C,D, eNOS monomeri-
zation in HUVECs promoted by dextrin (0.86 ± 0.01 arbitrary units, n = 4) was prevented by treatment with 
BH4 (2.03 ± 0.06 arbitrary units, n = 4), L-arginine (1.28 ± 0.07 arbitrary units, n = 4), or BH4 plus L-arginine 
(2.23 ± 0.08 arbitrary units, n = 4) as compared to the HUVECs control (1.41 ± 0.06 arbitrary units, n = 4).
eNOS uncoupling is associated with increased ROS levels and decreased NO production. The DHE fluores-
cence became more intense in HUVECs in the presence of dextrin (3631 ± 46, n = 8) and dextrin plus A23187 
(3340 ± 31, n = 8). However, pre-treatment with BH4 (2452 ± 41, n = 8), L-arginine (2597 ± 48, n = 8), BH4 plus 
L-arginine (2696 ± 45, n = 8), or L-NAME (2589 ± 54, n = 8) diminished the DHE fluorescence to the same level 
as the control group (2492 ± 49, n = 8) (Fig. 8G). On the other hand, NO measured in the HUVECs with the 
aid of the DAF-2DA probe decreased in the presence of dextrin (1000 ± 48, n = 8) as compared to the control 
(1589 ± 40, n = 8). In the presence of BH4 (2407 ± 47, n = 8), L-arginine (2239 ± 71, n = 8), or BH4 plus L-arginine 
(2449 ± 22, n = 8), the DAF-2DA fluorescence intensity increased above the baseline levels (Fig. 8E).
In another set of experiments, both dextrin (4030 ± 201, n = 6), L-NAME (3554 ± 70, n = 6) or dextrin plus 
L-NAME (3007 ± 102, n = 6) decreased DAF-2DA fluorescence intensity compared to control (5418 ± 96, n = 6). 
While BH4 (6887 ± 145, n = 6) or dextrin plus BH4 (6123 ± 296, n = 6) increased the fluorescence intensity of 
DAF-2DA above the levels of control group (Fig. 8F).
Discussion
This study has shown that caveolae-like structures is decreased in SHR aortas and mesenteric arteries compared 
to normotensive rats. In addition, impairment of ACh-induced endothelium-dependent relaxation could be 
related to decreased caveolae density in SHR vessels. The most important finding of this study was that choles-
terol depletion due to the presence of dextrin induced eNOS phosphorylation at Ser1177 and greatly increased 
Phenylephrine
Wistar SHR
Aorta (Control) Aorta (Dextrin) Aorta (Control) Aorta (Dextrin)
Maximum contractile 
effect (mN) 21.0 ± 2.1, n = 6 34.7 ± 1.3**, n = 8** 18.7 ± 2.8, n = 7 32.5 ± 3.7**, n = 7
pD2 6.5 ± 0.2, n = 6 6.8 ± 0.4, n = 8 7.0 ± 0.2, n = 7 7.3 ± 0.2, n = 7
Mesenteric artery 
(Control)
Mesenteric artery 
(Dextrin)
Mesenteric artery 
(Control)
Mesenteric artery 
(Dextrin)
Maximum contractile 
effect (mN) 16.2 ± 1.4, n = 6 18.8 ± 1.4, n = 5 17.4 ± 1.3, n = 6 21.2 ± 1.7, n = 7
pD2 6.3 ± 0.1, n = 6 6.9 ± 0.1*, n = 5 6.0 ± 0.1, n = 6 6.4 ± 0.1*, n = 7
Table 1. Maximum contractile effect and pD2 (Negative logarithm of the EC50, concentration of the agent that 
produced half-maximal amplitude) induced by phenylephrine in aortas and mesenteric arteries of Wistar and 
SHR, treated (dextrin) or not (control) with dextrin (10 mM for 60 min). *p < 0.05 and **p < 0.01 between 
Dextrin versus Control groups.
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ROS production in normotensive rat and SHR vessels, which suggested eNOS uncoupling (Fig. 9). Treatment 
of HUVECs with dextrin confirmed eNOS uncoupling, as evidenced by the lower eNOS dimer/monomer ratio. 
The presence of BH4, L-arginine, or BH4 plus L-arginine inhibited eNOS monomerization. These results showed 
that a reduction in the number of caveolae was associated with hypertension disease, and that caveolae disruption 
promoted eNOS uncoupling.
It is widely accepted that the formation of caveolae structure requires the expression of Cav-16,7. A lower num-
ber of caveolae was observed in SHR vessels when compared to normotensive rat before dextrin treatment (Figs 3 
and 4). Corroborating this data, Cav-1 expression was diminished in SHR aorta compared to normotensive rat 
(Fig. 5E). However, Cav-1 expression was similar in mesenteric arteries of SHR and normotensive rat (Fig. 5F). 
In an excellent review, the conditions that are necessary for caveolae structure to be formed are discussed28. 
After Cav-1 is synthetized in the endoplasmic reticulum, an oligomerization process takes place that is depend-
ent on caveolin-2 and participation of the 8S complex on sucrose gradients29. This step of 8S-oligomerization 
appears to be essential for the proper formation of caveolae, because Cav-1 that fail to oligomerize are unable to 
independently turnover into caveolae30,31. In addition, the cavins are proteins that act as support or adapter to 
caveolae formation and in its absence the caveolae assembly is compromised in vivo in all tissues32. Also, cavin-1 
knock-down significantly reduces caveolae number in both mammalian cells and zebrafish33. It is possible that 
Figure 3. (A) Identification of caveolae-like structures on the surface of intact endothelial cells of normotensive 
rats and SHR aortas by transmission electron microscopy. General arrangement representative of the control 
groups on the left side and of the groups treated with methyl-β-cyclodextrin (10 mM dextrin, for 60 min) on the 
right side. Original magnification of 50,000× and 0.5-μm scale bar in each case. (B) Number of caveolae/μm2 in 
aortic endothelial cells from normotensive rats and SHRs, treated with methyl-β-cyclodextrin (dextrin) or not 
(control). Bars represent the mean ± SEM of five electron micrographs counted in areas of similar magnitudes. 
The values are expressed as the number of caveolae per area (μm2). **p < 0.01 statistical difference in caveolae 
density values between Dextrin versus Control groups in both normotensive rats and SHRs; #p < 0.05 statistical 
difference in caveolae density in the control groups between SHRs versus normotensive rats; &p < 0.05 statistical 
difference in caveolae density in SHRs treated with dextrin versus other groups.
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other factors are not discussed here, which are required for caveolae formation are unregulated in mesenteric 
arteries of SHR. Further studies are required to pinpoint which step of the signaling pathway that result in caveo-
lae formation is defective in resistance vessels of SHR.
PE-induced contraction in normotensive rat and SHR aortas and mesenteric arteries presented similar ampli-
tude (Fig. 2A,B). After caveolae disruption, the PE-stimulated maximum contractile effect increased in normo-
tensive rat and SHR aortas (Fig. 2C,E), and the PE potency intensified in normotensive rat and SHR mesenteric 
arteries (Fig. 2D,F). In contrast to our findings, a study that used male Sprague-Dawley rat aortic rings with intact 
endothelium reported that dextrin does not modify smooth muscle contractile responses to PE, which suggested 
that this α-adrenergic agonist does not require the presence of signaling molecules in cholesterol-rich domains 
to cause contraction34. Dreja and colleagues35 demonstrated that the α1-adrenergic-selective agonist cirazoline 
promotes similar contractions in rat-tail endothelium-denuded artery rings before and after treatment with dex-
trin. However, the increased PE contractile effect promoted by dextrin and verified herein could be related to 
release of lower basal NO levels after treatment with dextrin in both aortas and mesenteric arteries (Figs 6A and 
8B). Moreover, caveolae disruption in rat femoral arteries was reported not only to reduce basal NO levels, but 
also to decrease the involvement of BKCa channels in smooth muscle cell membrane potential and consequently 
arterial contraction36. Furthermore, ROS levels in normotensive rat and SHR aortas and mesenteric arteries were 
Figure 4. (A) Representative electron micrographs of caveolae-like structures in normotensive rat and 
SHR mesenteric arteries treated with methyl-β-cyclodextrin (10 mM dextrin, for 10 min, right side) or not 
(control, left side). Original magnification of 50,000× and 0.5-μm scale bar in each case. (B) Number of 
caveolae/μm2 in mesenteric artery endothelial cells from normotensive rats and SHR treated with methyl-β-
cyclodextrin (dextrin) or not (control). Bars represent the mean ± SEM of five electron micrographs counted 
in areas of similar magnitudes. The values are expressed as the number of caveolae per area (μm2). **p < 0.01 
statistical difference in caveolae density values between Dextrin versus Control groups in both normotensive 
rats and SHRs; #p < 0.05 statistical difference in caveolae density in the control groups between SHRs versus 
normotensive rats; &p < 0.05 statistical difference in caveolae density in SHRs treated with dextrin versus other 
groups.
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higher after treatment with dextrin (Fig. 7A,B), and these ROS could contribute to the contraction of underlying 
smooth muscle cells37.
ACh-induced endothelium-dependent relaxation diminished in normotensive rat and SHR aortas and mes-
enteric arteries (Fig. 1A,B), corroborating with previous studies showing that this impairment is due to different 
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Figure 5. Representative western blot of total eNOS (top blot), eNOS phosphorylation at Serine1177 (top 
blot), caveolin-1(top blot), and GAPDH (bottom blot; loading control) in normotensive rat and SHR aortas 
(A,C,E) and mesenteric arteries (B,D,F) treated with methyl-β-cyclodextrin (10 mM dextrin, for 60 min) or not 
(Control). We processed images of blots changing brightness and contrast and we applied equally over the entire 
image and controls. *p < 0.05, **p < 0.01, ***p < 0.001 statistical difference between Dextrin versus Control 
groups; #p 0.05 statistical difference between SHR versus normotensive rat groups.
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mechanisms associated with hypertension, aging24,38,39 and vascular smooth muscle cells40. In addition, this 
endothelium-dependent relaxation impairment could be related to a lower number of caveolae in SHR aortas 
(Fig. 3) and mesenteric arteries (Fig. 4). A smaller number of caveolae was attributed to impaired ACh-induced 
relaxation impaired in the renal hypertensive model (2K-1C)26. Another study reported a greater number of cav-
eolae in myocardium of ten-week-old SHRs (early stage of hypertension with significant cardiac hypertrophy) as 
compared to WKY of the same age. In 20-week-old SHRs with established hypertension and cardiac hypertrophy, 
the caveolae observed in 10-week-old SHRs no longer exist41. On the basis of these findings, caveolae play a role 
in the process of cardiovascular diseases, and caveolae absence or loss underlies hypertension.
eNOS is enriched in plasma membrane caveolae, and eNOS activity is nine- to ten-fold more prevalent in the 
caveolar fraction as compared to whole plasma membrane42. Normotensive rat and SHR aortas and in mesenteric 
arteries had similar basal eNOS expression (Fig. 5A,B). On the other hand, eNOS activity indirectly measured by 
the Griess assay was lower in SHR vessels as compared to normotensive rat vessels (Fig. 6A,B), which could be 
associated with decreased caveolae density in SHR vessels (Figs 3 and 4). After treatment with dextrin, the num-
ber of caveolae in SHR aortas and in mesenteric arteries decreased (Figs 3 and 4), so we can suggest that eNOS 
association with caveolae also reduced. Therefore, treatment with dextrin diminished eNOS expression just in 
SHR vessels (Fig. 5A,B).
Caveolae structural disruption with dextrin in normotensive rats abated ACh potency in aortas and 
the ACh-induced maximum relaxant effect in mesenteric arteries (Fig. 1C,D). In SHRs, dextrin reduced the 
ACh-stimulated maximum relaxant effect in both vessels (Fig. 1E,F). Different studies reported decreased NO 
release and impaired ACh-induced relaxation after caveolae disruption14,16,26,34, confirming that caveolae struc-
ture and integrity are essential for endothelium-dependent relaxation. Therefore, we focused on the mechanisms 
ensuing after caveolae disruption.
As mentioned previously, the most important finding of our study was that cholesterol depletion in caveolae 
due to the presence of dextrin induced eNOS phosphorylation at Ser1177 in normotensive rat and SHR vessels 
(Fig. 5C,D). This response was followed by reduced NO production (Fig. 6) and increased ROS levels (Fig. 7) 
in ACh-stimulated vessels obtained from normotensive rats and SHRs. Although eNOS phosphorylation at the 
Ser1177 residue regulates NO generation43,44, Ser1177 phosphorylation in uncoupled eNOS increases the ROS gen-
eration rate45. To show that, researchers stimulated purified BH4-free human endothelial NOS (heNOS) with AKT 
and PKCα, to observe Ser1177 phosphorylation in heNOS as well as 54% increase in ROS generation. However, 
ROS generation produced by heNOS Thr495 phosphorylation does not elicit any significant effects as compared 
to the control enzyme45. In order to confirm that eNOS is the source of NO and ROS production, we performed 
Figure 6. NOx levels in normotensive rat and SHR aortic (A,C) and mesenteric artery (B,D) rings treated with 
methyl-β-cyclodextrin (10 mM dextrin, for 60 min) or not (control) (n = 5–10). Some rings were incubated in 
presence of L-NAME (1 mM, 30 min) or BH4 (100 µM, 30 min) (C,D). Bars represent the mean ± SEM of the 
experiments, and n represents bath solutions from the different aortic or mesenteric artery rings used herein. 
*p < 0.05 statistical difference in NOx level values between Dextrin or Dextrin plus L-NAME versus Control 
groups; #p < 0.05 statistical difference in NOx level values in control groups between SHRs versus normotensive 
rats; &p < 0.05 statistical difference in NOx level between Dextrin plus BH4 versus Dextrin groups.
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experiments in the presence of L-NAME in aortic and mesenteric rings, as well as in HUVEC. We showed that 
dextrin plus L-NAME did not add their effects or promoted an increased NOx levels, confirming that NO is 
derived from NOS (Figs 6C,D and 8F). In addition, the fluorescence intensity of 7-CBA increased by dextrin 
treatment was damped in presence of L-NAME or BH4 (Fig. 7C,D). Therefore, our results suggest that caveolae 
disruption promotes eNOS uncoupling in normotensive rat and SHR vessels.
To corroborate that cholesterol depletion in caveolae promotes eNOS uncoupling, we treated HUVECs with 
dextrin. The eNOS dimer/monomer ratio decreased (Fig. 8A,B). In addition, NO levels measured by DAF-2DA 
(Fig. 8E,F) were reduced, and ROS generation (Fig. 8G) measured by DHE augmented in HUVECs treated with 
dextrin, which confirmed eNOS uncoupling. This uncoupling occurs when either the substrate L-arginine or the 
redox active cofactor BH4 is not present46,47. Hence, pretreatment with BH4, L-arginine, or BH4 plus L-arginine 
avoided dextrin-induced eNOS monomerization in HUVECs (Fig. 8C,D). Moreover, these pretreatments boosted 
NO levels (Fig. 8E,F) and decreased ROS generation (Fig. 8G). The nonselective NOS inhibitor L-NAME also 
reduced the ROS levels induced by dextrin (Fig. 8G).
Figure 7. Reactive oxygen species (ROS) levels in normotensive rats and SHR aortic (A,C) and mesenteric 
artery (B,D) rings treated with methyl-β-cyclodextrin (10 mM dextrin for 60 min) or not (control) (n = 5), as 
measured with the coumarin-7-boronate acid (7-CBA) fluorescence probe. Some rings were incubated with 
L-NAME (1 mM, 30 min) or BH4 (100 µM, 30 min). Bars represent the mean ± SEM of the experiments, and n 
represents bath solutions from the different aortic or mesenteric artery rings used herein. *p < 0.05 statistical 
difference in ROS level values between Dextrin versus Control groups; #p < 0.05 statistical difference in ROS 
level values in control groups between SHR versus normotensive rats; &p < 0.05 statistical difference in ROS 
levels between Dextrin plus L-NAME or Dextrin plus BH4 versus Dextrin groups.
Groups Aorta (Control) Aorta (Dextrin) Aorta (Dextrin + L-NAME) Aorta (Dextrin + BH4)
Fluorescence intensity of 
7-CBA (a.u.)
Wistar 9593 ± 831, n = 5 16280 ± 1210*, n = 5 9290 ± 829&, n = 5 9146 ± 275&, n = 5
SHR 15030 ± 1328, n = 5 22580 ± 2562*, n = 5 14390 ± 1580&, n = 5 12060 ± 1649&,n = 5
Mesenteric artery 
(Control)
Mesenteric artery 
(Dextrin)
Mesenteric artery 
(Dextrin + L-NAME)
Mesenteric artery 
(Dextrin + BH4)
Fluorescence intensity of 
7-CBA (a.u.)
Wistar 2489 ± 103, n = 5 3645 ± 165*, n = 5 2507 ± 183&, n = 5 2330 ± 161&, n = 5
SHR 3625 ± 171, n = 5 4334 ± 84*, n = 5 3496 ± 173&, n = 5 3747 ± 95&, n = 5
Table 2. Reactive oxygen species (ROS) production measured in aortas and mesenteric arteries of 
normotensive and SHR, treated (dextrin) or not (control) with dextrin (10 mM for 60 min). Some rings were 
incubated with L-NAME (1 mM for 30 min) or BH4 (100 µM for 30 min). *p < 0.05 between Dextrin versus 
Control groups. &p < 0.05 between Dextrin plus L-NAME or BH4 versus Dextrin group.
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Taken together, our results confirm that caveolae structure and integrity are essential for 
endothelium-dependent relaxation. Additionally, a smaller number of caveolae is associated with hypertension. 
Finally, caveolae disruption promotes eNOS uncoupling in normotensive and hypertensive rat vessels and in 
HUVECs.
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Figure 8. (A,C) Representative western blot of eNOS dimer/monomer distribution in unboiled samples 
(top blot) and GAPDH or α-tubulin (bottom blot; loading control) in human umbilical vein endothelial cells 
(HUVECs) treated with methyl-β-cyclodextrin (10 mM dextrin for 60 min) or not (Control). (B,D) Basal 
changes in eNOS dimer and monomer induced by dextrin, in the presence of tetrahydrobiopterin (BH4, 
100 μM), L-arginine (L-arg, 1 mM), or BH4 plus L-arg or not. We processed images of blots changing brightness 
and contrast and we applied equally over the entire image and controls. (E,F) NO determination with the DAF-
2DA probe in HUVECs treated with dextrin or not (Control) in the presence of BH4, L-arg, L-NAME (1 mM), 
or BH4 plus L-arg. (G) Reactive oxygen species (ROS) detected with the DHE probe in the presence of BH4, 
L-arg, BH4 plus L-arg, L-NAME, or A23187 (5 μM) in HUVECs treated with dextrin or not. Bars are reported 
as the mean ± SEM of independent experiments (n = 4–5). Values of blank were not use to perform statistics. 
*p < 0.05 statistical differences between Dextrin versus control group. #p < 0.05 between dextrin (in the 
presence of BH4, or L-arg, or BH4 plus L-arg) and only BH4 versus Dextrin group. &p < 0.05 between L-NAME, 
dextrin plus L-NAME or A23187 versus Control group.
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Material and Methods
The Animal Care and Use Committees of the University of São Paulo (License CEUA 17.1.127.60.2) and the São 
Paulo State University (License CEUA 00423-2017) approved all the experimental protocols, which were con-
ducted in accordance to the US National Institutes of Health (NIH Publication No. 85–23, revised 1996).
Drugs. Phenylephrine (PE, L-phenylephrine hydrochloride), acetylcholine (ACh, acetylcholine chloride), 
methyl-β-cyclodextrin (dextrin), Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME), dihydroethidium 
(DHE), calcium ionophore (A23187), 4,5-diaminofluorescein diacetate (DAF-2DA), N-(1-Naphthyl)ethylenedi-
amine dihydrochloride, sulfanilamide, sodium nitrite and L-arginine were obtained from Sigma-Aldrich (St. 
Louis, MO – United States).
Coumarin-7-boronic acid (7-CBA) and tetrahydro-L-biopterin hydrochloride (BH4) were purchased from 
Cayman Chemical (Ann Arbor, MI – United States).
Animals. Male SHRs (~300 g) aged 90 days and with systolic blood pressure ≥150 mmHg were used in the 
experiments. Age-matched male normotensive Wistar rats (~450 g) with systolic blood pressure ≤110 mmHg 
were employed as control. The systolic blood pressure was evaluated by tail plethysmography (PowerLab, 
ADInstruments, Melbourne, VIC – Australia). The animals were housed under standard laboratory conditions 
(at 22 ± 2 °C and under 12-h light/dark cycles) with free access to food and water.
Vessel preparation. The Wistar (designated normotensive) rats and the SHRs were submitted to inhalation 
of isoflurane (BioChimico®, Itatiaia, RJ – Brazil), decapitated, and exsanguinated. Thoracic aortas and mesen-
teric artery beds were placed in two different Petri dishes containing cold Krebs-Henseleit solution [mM] (NaCl 
130.00, NaHCO3 14.9, C6H12O6 5.5, KCl 4.7, KH2PO4 1.18, MgSO4 1.17, and CaCl2 1.6; pH 7.4). The thoracic 
aortas and the mesenteric arteries were cleaned of connective tissue with the aid of a stereomicroscope (Luxeo 2S, 
Labomed, Los Angeles, CA – United States).
Aorta ring vascular reactivity. The thoracic aortas were cut into 2-mm rings. To measure the isomet-
ric tension, the rings were placed between two stainless steel stirrups of a myograph (DMT, Melbourne, VIC 
– Australia). To develop basal active tension, the aortic rings were stretched until they reached 30 mN. Then, 
the rings were left under basal resting tension in oxygenated Krebs-Henseleit solution (95% O2 and 5% CO2; ph 
7.4) at 37 °C for 60 min. Next, the rings were contracted with PE (1 µM), and the endothelial cell integrity was 
confirmed by over 90% and 70% relaxation in the aortas of Wistar rats and SHRs in response to ACh (10 µM), 
respectively. All the aortic rings used in this study presented intact endothelium.
Resistance mesenteric artery ring vascular reactivity. The second or the third branch of the mes-
enteric arteries (internal diameter = 200–300 µm) was cut into 2-mm-long rings. The isometric tension in these 
rings was measured with a myograph (DMT, Melbourne, VIC – Australia). More specifically, two tungsten wires 
with diameter of 40 µm were placed through the lumen of the vessel, which was mounted according to the method 
described by Mulvany and Halpern48. The mesenteric artery rings were stretched to their optimal lumen diameter, 
to develop active tension. Then, the mesenteric artery rings were left under basal resting tension in oxygenated 
Krebs-Henseleit solution (95% O2 and 5% CO2; at 37 °C and pH 7.4) for 30 min. After that, the mesenteric artery 
rings were contracted with PE (1 µM), and over 80% and 60% relaxation in the arteries of Wistar rats and SHRs 
in response to ACh (10 µM), respectively, confirmed endothelial cell integrity. All mesenteric artery rings used in 
this study presented intact endothelium.
eNOS 
coupled
Ser1177-℗
L-arginine
O2
L-citrullineNO
A) Spontaneously Hypertensive Rats (SHR) 
No cholesterol 
depletion
Caveolae
Caveolin-1
eNOS 
uncoupled
Ser1177-℗
L-arginine
O2
O2•¯
Endothelial cell Disruption of Caveolae using methyl-β-cyclodextrin
(dextrin)
L-citrulline
• Reduced caveolae density in arteries of SHR
Endothelial cell
B) Spontaneously Hypertensive Rats (SHR) 
• Dextrin further reduced the number of
caveolae in the SHR arteries
Figure 9. (A) Representative scheme of reduced caveolae density in endothelial cells of SHR arteries without 
cholesterol depletion. The eNOS is still able to produce NO. (B) In presence of methyl-β-cyclodextrin (dextrin) 
occurs disruption of caveolae structure promoting reduction of caveolae density and eNOS uncoupling, leading 
to superoxide production.
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protocols. Cumulative concentration–response curves were constructed by using ACh and PE at concentra-
tions ranging from 0.1 nM to 100 µM for the aortic rings and mesenteric artery rings of normotensive rats and 
SHRs in the absence of dextrin (control) or after incubation with dextrin (10 mM) for 60 min. To construct the 
concentration-response to ACh curves, the rings were contracted with PE (10 µM).
transmission electron microscopy. Procedures were performed as described by Moreira and collabora-
tors49. Briefly, thoracic aortas and mesenteric artery rings treated with dextrin (10 mM) for 60 min or not (con-
trol) were fixed by immersion in a solution containing glutaraldehyde 2%, paraformaldehyde 2%, and sodium 
cacodylate buffer (0.1 M) for 12 h. After that, the preparations were kept in sodium cacodylate (0.1 M) at 4 °C 
until the next step was conducted. Post-fixation was carried out in osmium tetroxide 1% for 1 h. The samples were 
submitted to dehydration in a graded series of pure acetone. Then, the sample infiltration process was performed 
with a combination of Araldite resin and pure acetone (1:1 ratio overnight; 2:1 ratio for 4 h; 3:1 ratio for 4 h; and 
100% resin for 24 h). Next, the material was polymerized with Araldite resin at 60 °C for 72 h. The plastic blocks 
were trimmed, and the 0.5-μm semi-thin sections (Leica ultra-microtome, Wetzlar, Germany) were stained with 
toluidine blue 1% to choose the appropriate areas for ultrathin sectioning (60–70 nm). Ultrathin sections were 
collected on Pyoloform and carbon-coated single-slot grids, and they were contrasted with uranyl acetate and 
lead citrate.
Electron micrographs were taken at an initial magnification of 10,000× and were photographically enlarged 
on the computer screen to a magnification of 50,000× with a transmission electron microscope (Hitachi H7500). 
Morphometry and quantitative analysis were performed with the ImageJ software from the National Institutes 
of Health. The caveolae were counted on the edge of the endothelial cell membrane. Results are expressed as the 
number of caveolae per square micrometer of the cell.
Western Blot. The thoracic aortas and mesenteric arteries treated with dextrin (10 mM) for 60 min or not 
(control) were cleaned, frozen in liquid nitrogen, and stored at −80 °C. The samples were macerated in RIPA 
buffer supplemented with a cocktail of protease and phosphatase inhibitors. The homogenates were centrifuged at 
4 °C and 12,000 rpm for 20 min, and the supernatants were collected for protein determination50. The total protein 
(10 μg) obtained from each sample was submitted to electrophoresis on polyacrylamide gel 12% and transferred 
to a nitrocellulose membrane. Then, the membrane was blocked with non-fat milk 5% for 1 h and incubated with 
primary antibodies against eNOS (1:1000, BD Bioscience, 610296), Cav-1 (1:2000, BD Bioscience, 610406), and 
p-eNOS Ser1177 (1:1000, Millipore, 07–428) at 4 °C overnight. Next, the membrane was incubated with secondary 
anti-rabbit (1:2000) or anti-mouse (1:2000) antibodies at room temperature for 60 min. The bands were detected 
by chemiluminescence with a radiographic film. GAPDH (1:1000, Santa Cruz, sc-365062) was used to normalize 
the results. The bands were quantified with the ImageJ Software (NIH Image).
eNOS dimer/monomer low-temperature SDS-PAGE analyses. Human umbilical vein endothelial 
cells (HUVECs) were purchased from ATCC cell lines (American Type Culture Collection - Manassas, VA – 
United States) and cultured in growth medium (Dulbecco’s modified eagle’s medium – DMEM, Vitrocell, 00025) 
supplemented with fetal bovine serum (FBS) 10% from Gibco (12657029, South America) and used at passages 
4–6. After serum deprivation in culture medium for 12 h, confluent HUVECs were treated with dextrin (10 mM) 
for 60 min or not (control) in the presence of BH4 (100 μM, for 30 min), L-arginine (1 mM, for 30 min), or BH4 
plus L-arginine. Then, the cultured cells were lysed on ice in RIPA buffer supplemented with a cocktail of protease 
and phosphatase inhibitors, and the lysates were placed under non-denaturing conditions. The samples were pre-
pared with 4x Laemmli sample buffer (Biorad, 1610747) plus betamercaptoethanol 10% (Biorad, 1610710) and 
were loaded on polyacrylamide gel 8%. During electrophoresis and protein transfer to the nitrocellulose mem-
brane, the buffers were placed in an ice-water bath, and the whole apparatus was kept at 4 °C. The eNOS monomer 
and dimer forms were incubated with antibody against eNOS (1:1000, BD Bioscience, 610296) and α-tubulin or 
GAPDH were used to normalize the results. The bands were detected by a chemiluminescence substrate (Santa 
Cruz, SC-2048).
Colorimetric Griess reaction. The thoracic aorta and mesenteric artery rings of normotensive rats and 
SHRs were incubated in a bath chamber containing Krebs-Henseleit solution (95% O2 and 5% CO2; pH 7.4) at 
37 °C. The rings were treated with dextrin (10 mM) for 60 min or not (control). Some rings were incubated in 
the presence of L-NAME (1 mM, 30 min) or BH4 (100 µM, 30 min). Then, each sample was stimulated with PE 
(10 μM) followed by ACh (10 μM). Next, 50 μL of the bath solution of each sample was collected and added to 
50 μL of Griess reagent (a 1:1 dilution of N-(1-Naphthyl)ethylenediamine dihydrochloride 1% in distilled water 
and sulfanilamide 1% in phosphoric acid 5%) in a 96-well plate. Sodium nitrite was used as standard. The stand-
ard curve ranged from 3 μM to 200 μM for nitrite. The absorbance was read at 540 nm. The results were normal-
ized to total protein.
Reactive oxygen species (ROS) production measurement with coumarin-7-boronate acid 
(7-CBA) or DHE probe. In a bath chamber, the thoracic aorta and mesenteric artery rings of normotensive 
rats and SHRs were incubated in 95% O2 and 5% CO2, pH 7.4, at 37 °C in the absence (control) or presence of 
dextrin (10 mM) for 60 min. Some rings were incubated with L-NAME (1 mM, 30 min) or BH4 (100 µM, 30 min). 
The rings were stimulated with PE (10 μM) followed by ACh (10 μM). Then, 50 μL of the bath solution of each 
sample was collected and added to 50 μL of 7-CBA (20 µM) for 30 min. The bath solution of each sample plus the 
probe was placed in a 96-well plate. The results were normalized to total protein.
The HUVECs were grown in a 96-well assay plate, washed twice with PBS (phosphate buffered saline), 
and incubated with medium containing DHE (2.5 μM) for 60 min. Then, the HUVECs were treated with 
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dextrin (10 mM) for 60 min or not (control), which was followed by pretreatment with BH4 (100 μM, for 30 min), 
L-arginine (1 mM, for 30 min), L-NAME (100 μM, for 30 min), A23187 (5 μM, for 5 min), or BH4 plus L-arginine.
Fluorescence analysis of the oxidation product 7-OH-coumarin (COH, 332 nm/447 nm – Excitation/
Emission)51 and the fluorescence produced by DHE (370 nm/420 nm – Excitation/Emission) were obtained on a 
SpectraMax M5 Microplate Reader (Molecular Advices, Sunnyvale, CA, United States).
NO measurement with DAF-2DA probe. The HUVECs were grown in a 96-well assay plate, washed 
twice with PBS (phosphate buffered saline), and incubated with medium (DMEM, 0% FBS) containing DAF-2DA 
(2.5 μM) for 60 min. Then, the HUVECs were treated with dextrin (10 mM) for 60 min or not (control), which 
was followed by pretreatment with BH4 (100 μM, for 30 min), L-arginine (1 mM, for 30 min), L-NAME (1 mM, 
for 30 min) or BH4 plus L-arginine. The fluorescence produced by DAF-2DA was measured at 488 nm/530 nm 
(Excitation/Emission) on a SpectraMax M5 Microplate Reader (Molecular Advices, Sunnyvale, CA).
statistical analysis. For the functional studies, the EC50 (concentration of the agent that produced 
half-maximum amplitude) values were determined after logarithmic transformation of the normalized concen-
tration–response curves and are reported as the negative logarithm (pD2). The maximum effect (ME) values are 
represented as percentage and are considered as the maximum amplitude response reached in the concentra-
tion−effect curves for the relaxation or contractile agents. The results are expressed as the mean ± standard error 
of the mean (SEM) of the obtained values; n indicates the number of animals, the number of thoracic aorta rings, 
or the number of mesenteric artery rings that were used in the experiments. In the experiments that employed 
HUVECs, n indicates independent experiments.
Two groups were compared by Student’s t-test; three or more groups were compared by one-way ANOVA with 
Tukey post-hoc test. Statistical analysis was performed with the Prism GraphPad 5.0 software. Differences were 
considered statistically significant when p < 0.05.
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